While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. That said, here are three cash-producing companies that don’t make the cut and some better opportunities instead.
AT&T (T)
Trailing 12-Month Free Cash Flow Margin: 13.9%
Founded by Alexander Graham Bell, AT&T (NYSE:T) is a multinational telecomm conglomerate providing a range of communications and internet services.
Why Do We Avoid T?
- Flat sales over the last five years suggest it must innovate and find new ways to grow
- Performance over the past five years shows each sale was less profitable, as its earnings per share fell by 6.9% annually
- Free cash flow margin is not anticipated to grow over the next year
AT&T’s stock price of $24.45 implies a valuation ratio of 10.1x forward P/E. To fully understand why you should be careful with T, check out our full research report (it’s free).
The Pennant Group (PNTG)
Trailing 12-Month Free Cash Flow Margin: 3.2%
Spun off from The Ensign Group in 2019 to focus on non-skilled nursing healthcare services, Pennant Group (NASDAQ:PNTG) operates home health, hospice, and senior living facilities across 13 western and midwestern states, serving patients of all ages including seniors.
Why Are We Cautious About PNTG?
- Smaller revenue base of $1.09 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
- Ability to fund investments or reward shareholders with increased buybacks or dividends is restricted by its weak free cash flow margin of 2.4% for the last five years
- High net-debt-to-EBITDA ratio of 6× increases the risk of forced asset sales or dilutive financing if operational performance weakens
At $39.96 per share, The Pennant Group trades at 27.2x forward P/E. If you’re considering PNTG for your portfolio, see our FREE research report to learn more.
Bruker (BRKR)
Trailing 12-Month Free Cash Flow Margin: 2.7%
With roots dating back to the pioneering days of nuclear magnetic resonance technology, Bruker (NASDAQ:BRKR) develops and manufactures high-performance scientific instruments that enable researchers and industrial analysts to explore materials at microscopic, molecular, and cellular levels.
Why Are We Wary of BRKR?
- Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
- Earnings per share were flat over the last five years while its revenue grew, showing its incremental sales were less profitable
- Diminishing returns on capital suggest its earlier profit pools are drying up
Bruker is trading at $60.57 per share, or 28.4x forward P/E. Read our free research report to see why you should think twice about including BRKR in your portfolio.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.